Professor Grant welcomes NIMR relocation to UCL
24 February 2005
The Medical Research Council (MRC) and University College London (UCL) are pleased to announce the unanimous decision by the MRC Council that UCL is to be the preferred partner for the development of the full Science and Business Case for the renewal of the National Institute for Medical Research (NIMR).
UCL, together with its associated hospital trusts, offers an environment within which fundamental biological, biomedical and clinical research are integrated, and in which translation into advances in diagnostics, therapeutics and patient care is the driver as well as the outcome of such research. NIMR enjoys an international reputation as a centre of excellence in areas such as infection and immunity, developmental biology and neuroscience underpinned by structural and cell biology and genetics. Considerable synergies already exist between the two institutions and close physical proximity will enable extant collaborations to be expanded and new partnerships to be developed.
UCL President and Provost Malcolm Grant said: "This promises to be a fertile marriage between two powerful institutions. The NIMR will benefit from its new proximity to the many major hospitals associated with UCL, along with the enormous investments in basic science and translational medical science that UCL has made in recent years. In turn, UCL will reap the rewards of a partnership with an institution of exceptional reputation in major areas of biomedical research.
"We shall develop a new relationship with NIMR that not only builds on our existing collaborations, but also breaks new ground for both institutions. UCL will do everything in its power to ensure the relocation proceeds as smoothly and as quickly as possible to enable everyone involved to pursue their research activities with the minimum disruption."
information about NIMR or to visit the President and Provost's website
use the links below.